Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Geographic atrophy: where we are now and where we are going

17 Mar 2021

Abstract excerpt

PURPOSE OF REVIEW: Age-related macular degeneration (AMD) affects a significant percentage of the elderly population and end-stage disease classified by either geographic atrophy (GA) or neovascular AMD (nvAMD) is one of the leading causes of vision loss worldwide. Despite the fact that there are currently treatments for nvAMD, there are no treatments in practice to prevent disease onset or progression of GA....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Retinal Development and Disorders
Share to Retinal Diseases and Treatments
Share to Retinal Imaging and Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33741759
DOI: 10.1097/icu.0000000000000763

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Geographic atrophy: where we are now and where we are goingPMID 33741759Read ↗

Structural OCT and OCT angiography biomarkers associated with the development and progression of geographic atrophy in AMDSemantic proximity Read ↗

Geographic atrophy in age-related macular degeneration: phenotypic characterisation for clinical trial consideration.Semantic proximity Read ↗

Incidence and progression of geographic atrophy: observations from a population-based cohort.Semantic proximity Read ↗

Mechanisms of age-related macular degeneration and therapeutic opportunities.Semantic proximity Read ↗

Treating patients with geographic atrophy: are we there yet?Semantic proximity Read ↗

Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration.Semantic proximity Read ↗

Early and intermediate age-related macular degeneration: update and clinical review.Semantic proximity Read ↗

Hyperreflective Choroidal Foci Characterization Supports the Existence of Different Clinical Phenotypes of Geographic Atrophy.Semantic proximity Read ↗

The roadmap to geographic atrophy treatment: A journey of trials and promiseSemantic proximity Read ↗

Geographic Atrophy Phenotypes in Subjects of Different Ethnicity: Asia-Pacific Ocular Imaging Society Work Group Report 3.Semantic proximity Read ↗

Age‐related macular degeneration—clinical review and genetics updateSemantic proximity Read ↗

Age-Related Macular Degeneration: Cellular and Molecular Signaling MechanismsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.